146 related articles for article (PubMed ID: 34974816)
1. Can anti-PGL-I antibody isotypes differentiate leprosy contacts and leprosy patients?
Albuquerque AA; Dos Santos Mateus C; de Oliveira Rodrigues R; Lima ÉS; Lima LO; da Silva RL; Fernandes MAM; de Macedo AC; Tavares CM; Nogueira PSF; Nagao-Dias AT
Pathog Glob Health; 2022 Dec; 116(8):477-484. PubMed ID: 34974816
[TBL] [Abstract][Full Text] [Related]
2. Serum Anti-PGL-1 IgG, IgM, and IgA in a 3-Year Follow-up Study of 4-15-Year-old Leprosy Contacts.
TiemiNagao-Dias A; Casimiro de Macedo A; Rodrigues RO; Pedroza FHC; Albuquerque AA; Moreira FA; Santos Mateus CD; Tavares CM; Prata de Almeida TL
Pediatr Infect Dis J; 2019 Sep; 38(9):e193-e198. PubMed ID: 31220042
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-phenolic glycolipid-1 IgA correlates to IgM isotype in leprosy patients: a possible candidate for seroepidemiological surveys?
de Macedo AC; Guimarães JA; Rodrigues RO; Araújo TDV; Tavares CM; Cabral PB; de Moraes-Pinto MI; Nagao-Dias AT
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28594117
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
5. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
[TBL] [Abstract][Full Text] [Related]
6. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
[TBL] [Abstract][Full Text] [Related]
7. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
Chujor CS; Bernheimer H; Levis WR; Schwerer B
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
[TBL] [Abstract][Full Text] [Related]
8. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
[TBL] [Abstract][Full Text] [Related]
9. Salivary anti-PGL IgM and IgA titers and serum antibody IgG titers and avidities in leprosy patients and their correlation with time of infection and antigen exposure.
Nagao-Dias AT; Almeida TL; Oliveira Mde F; Santos RC; Lima AL; Brasil M
Braz J Infect Dis; 2007 Apr; 11(2):215-9. PubMed ID: 17625764
[TBL] [Abstract][Full Text] [Related]
10. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
[TBL] [Abstract][Full Text] [Related]
11. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
[TBL] [Abstract][Full Text] [Related]
12. Detection of Anti-Phenolic Glycolipid-I antibody in sera from tuberculosis patients in Bandung, West Java, Indonesia.
Gunawan H; Roslina N; Agusni JH; Kulsum ID; Makarti K; Hindritiani R; Suwarsa O
Int J Mycobacteriol; 2019; 8(2):166-169. PubMed ID: 31210160
[TBL] [Abstract][Full Text] [Related]
13. Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.
Nahas AA; Lima MIS; Goulart IMB; Goulart LR
Front Immunol; 2018; 9():1205. PubMed ID: 29904387
[TBL] [Abstract][Full Text] [Related]
14. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
[TBL] [Abstract][Full Text] [Related]
15. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
16. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
17. Comparison of IgM, IgG and IgA responses to M.leprae specific antigens in leprosy.
Praputpittaya K; Suriyanon V; Hirunpetcharat C; Rungruengthanakit K; Suphawilai C
Asian Pac J Allergy Immunol; 1990 Jun; 8(1):19-25. PubMed ID: 2203362
[TBL] [Abstract][Full Text] [Related]
18. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
[TBL] [Abstract][Full Text] [Related]
19. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
20. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
